DexCom, Inc. (DXCM)
66.37
-0.69
(-1.03%)
USD |
NASDAQ |
Dec 31, 16:00
66.49
+0.12
(+0.18%)
After-Hours: 20:00
DexCom Research and Development Expense (TTM): 590.40M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Abbott Laboratories | 2.897B |
| BioLife Solutions, Inc. | 25.07M |
| Krystal Biotech, Inc. | 55.37M |
| Boston Scientific Corp. | 1.943B |
| Tandem Diabetes Care, Inc. | 198.42M |